← All organizations

Io Therapeutics

For profitWebsite ↗

Also known as: Io Therapeutics | Io Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Mar 31, 2025

Timeline

2010s

Jun 1, 2010
Io Therapeutics— Founded

Drugs by trial phase (3 distinct, 4 trials)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

erlotinib

Indications

Studied for

Recent trials (5)

NCT06723171Lead sponsorPhase 2Mar 31, 2025
NCT02991651Lead sponsorPhase 1May 1, 2016
NCT02991651Study directorPhase 1May 1, 2016
NCT02438215Lead sponsorPhase 1Aug 1, 2014
NCT01540071Lead sponsorPhase 2Aug 1, 2011

Details

Founded: Santa Ana, CA, US Jun 1, 2010
Last known activity: Mar 31, 2025